For Immediate Release
April 13, 2021
Illinois Department of Public Health Pauses Use of Johnson & Johnson COVID-19 Vaccine
Illinois Follows CDC and FDA Guidance, Advises Providers to Use Moderna and Pfizer Doses for Existing Appointments
SPRINGFIELD - In accordance with recommendations from the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA), the Illinois Department of Public Health (IDPH) will pause the use of the Johnson & Johnson (J&J) COVID-19 vaccine out of an abundance of caution. The CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type blood clot in individuals after receiving the J&J vaccine.